# Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

> **NCT00003702** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 240 (actual)

## Conditions studied

- Good Prognosis Metastatic Gestational Trophoblastic Tumor
- Hydatidiform Mole
- Non-Metastatic Gestational Trophoblastic Tumor
- Uterine Corpus Choriocarcinoma

## Interventions

- **BIOLOGICAL:** Dactinomycin
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00003702
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2018-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003702, "Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*